Search

Showing "11155" results for ""

When to start HIV treatment: cohort studies disagree on how early

HIV sporadically detectable in semen of men with undetectable plasma viral loads

High-dose tenofovir microbicide completely protects monkeys

PrEP could work even if taken several days in advance

Risk of cancers with infectious cause going down in people with HIV

Antiretroviral treatment lowers rates of HIV transmission in heterosexual couples in Africa

Nearly half of new infant HIV infections in Botswana may result from mothers infected during pregnancy or after delivery

Certain protease inhibitors and abacavir linked to heart attacks in two large cohort studies

Two novel ‘enhancer’ drugs boost protease inhibitors as much as ritonavir

Switching from Kaletra to raltegravir improves lipid profiles at the risk of viral rebound

Interleukin-2 shows no benefit in two large clinical trials

Half of HIV/HCV co-infected early responders are cured with 72-week treatment

Corticosteroid therapy improves outcomes in people with TB-IRIS in trial

Maternal resistance to nevirapine following single dose reduced by AZT/ddI or one month's ART

Hospitalisation and disability are higher amongst HIV patients with hepatitis C coinfection

Ugandan study supports the use of fluconazole to prevent cryptococcal meningitis

Diabetes, high blood pressure and smoking raise risk of death for all people with HIV

Kaletra superior to nevirapine-based ART for women already exposed to single-dose nevirapine

Receive the latest HIV research and conference news

Showing "11155" results for ""

When to start HIV treatment: cohort studies disagree on how early

HIV sporadically detectable in semen of men with undetectable plasma viral loads

High-dose tenofovir microbicide completely protects monkeys

PrEP could work even if taken several days in advance

Risk of cancers with infectious cause going down in people with HIV

Antiretroviral treatment lowers rates of HIV transmission in heterosexual couples in Africa

Nearly half of new infant HIV infections in Botswana may result from mothers infected during pregnancy or after delivery

Certain protease inhibitors and abacavir linked to heart attacks in two large cohort studies

Two novel ‘enhancer’ drugs boost protease inhibitors as much as ritonavir

Switching from Kaletra to raltegravir improves lipid profiles at the risk of viral rebound

Interleukin-2 shows no benefit in two large clinical trials

Half of HIV/HCV co-infected early responders are cured with 72-week treatment

Corticosteroid therapy improves outcomes in people with TB-IRIS in trial

Maternal resistance to nevirapine following single dose reduced by AZT/ddI or one month's ART

Hospitalisation and disability are higher amongst HIV patients with hepatitis C coinfection

Ugandan study supports the use of fluconazole to prevent cryptococcal meningitis

Diabetes, high blood pressure and smoking raise risk of death for all people with HIV

Kaletra superior to nevirapine-based ART for women already exposed to single-dose nevirapine

Receive the latest HIV research and conference news